COVID-19Ministry of Health and Family WelfareHealthIndia

India’s Cumulative COVID-19 Vaccination Coverage exceeds 177.70 Cr

More than 18 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 98.59%

6,915 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 92,472

Weekly Positivity Rate is presently at 1.11%

With the administration of more than 18 lakh Doses (18,22,513) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 177.70 Cr (1,77,70,25,914) as per provisional reports till 7 am today.

This has been achieved through 2,04,61,239 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,01,609
2nd Dose 99,67,857
Precaution Dose 41,81,766
FLWs 1st Dose 1,84,09,585
2nd Dose 1,74,43,514
Precaution Dose 62,37,068
Age Group 15-18 years 1st Dose 5,48,91,370
2nd Dose 2,79,76,062
Age Group 18-44 years 1st Dose 55,18,71,141
2nd Dose 44,47,22,943
Age Group 45-59 years 1st Dose 20,22,82,358
2nd Dose 18,02,64,366
Over 60 years 1st Dose 12,64,19,524
2nd Dose 11,22,80,434
Precaution Dose 96,76,317
Precaution Dose 2,00,95,151
Total 1,77,70,25,914

 

16,864 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,23,24,550.

Consequently, India’s recovery rate stands at 98.59%.

6,915 new cases were reported in the last 24 hours.

India’s Active Caseload is presently at 92,472. Active cases constitute 0.22% of the country’s total Positive Cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 9,01,647 tests being conducted. India has so far conducted over 76.83 Cr (76,83,82,993) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 1.11% and the Daily Positivity rate is reported to be 0.77%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker